Aurora Fine Chemicals Ltd.
Company was founded in 1990. They adopted the name Aurora Fine Chemicals Ltd. in 1996. Aurora offers a drug discovery service, compound libraries and custom synthesis for pharmaceutical development and provides expert collaborative research services to the biotech and pharmaceutical industries. Their staff consists of highly qualified individuals with Bsc, Msc and Ph.D. degrees in chemistry, as well as excellent laboratory technicians. They possess many years experience of working in the chemistry of heterocycles, carbohydrates, nucleosides and elemental organic compounds.
The Molecular Modelling Group consists of professionals specializing in computational drug design. The power of the hit-to-lead and lead-to-drug candidate approach cannot be realized without strong synthetic chemistry skills. Aurora has significant expertise in synthesis of all types of small molecules, natural products and peptides in solution and in solid phase. Parallel synthesis with well-designed, targeted, small libraries is the favored approach to lead optimization. Rational design is the strategy for projects driven by structural biology, such as enzyme inhibitors or protein interactions.
For more information, please visit http://www.aurorafinechemicals.com